Review
Open access
Aug 2026
Therapeutic CRISPR/Cas9 delivery approaches: strengths, limitations, and a roadmap for clinical translation
A major focus of this review is the inclusion of recent hybrid systems (VLPs, SORT-LNPs) and the recognition that chemical modification of guide RNAs is a critical parameter for therapeutic success and that hybrid systems and stimuli-responsive nanoparticles are poised to dominate the next 5 years of clinical development.
M. Rezaee, F. Izadi, Saeed Nobaharian et al.
· Beni-Suef University Journal... · 0 citations